These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 24778572)

  • 1. Sarcoma immunotherapy: past approaches and future directions.
    D'Angelo SP; Tap WD; Schwartz GK; Carvajal RD
    Sarcoma; 2014; 2014():391967. PubMed ID: 24778572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy of Childhood Sarcomas.
    Roberts SS; Chou AJ; Cheung NK
    Front Oncol; 2015; 5():181. PubMed ID: 26301204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapeutic approaches to sarcoma.
    Burgess M; Tawbi H
    Curr Treat Options Oncol; 2015 Jun; 16(6):26. PubMed ID: 25975445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Manipulating the Immune System With Checkpoint Inhibitors for Patients With Metastatic Sarcoma.
    D'Angelo SP
    Am Soc Clin Oncol Educ Book; 2016; 35():e558-64. PubMed ID: 27249767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The potentiality of immunotherapy for sarcomas: a summary of potential predictive biomarkers.
    Liang J; Chen D; Chen L; She X; Zhang H; Xiao Y
    Future Oncol; 2020 Jun; 16(17):1211-1223. PubMed ID: 32396026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunotherapy: A New (and Old) Approach to Treatment of Soft Tissue and Bone Sarcomas.
    Nathenson MJ; Conley AP; Sausville E
    Oncologist; 2018 Jan; 23(1):71-83. PubMed ID: 28935774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunotherapy for sarcomas.
    Nakata E; Fujiwara T; Kunisada T; Ito T; Takihira S; Ozaki T
    Jpn J Clin Oncol; 2021 Apr; 51(4):523-537. PubMed ID: 33611603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging Targeted and Immune-Based Therapies in Sarcoma.
    Pollack SM; Ingham M; Spraker MB; Schwartz GK
    J Clin Oncol; 2018 Jan; 36(2):125-135. PubMed ID: 29220291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential for immunotherapy in soft tissue sarcoma.
    Tseng WW; Somaiah N; Engleman EG
    Hum Vaccin Immunother; 2014; 10(11):3117-24. PubMed ID: 25625925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospects for personalized combination immunotherapy for solid tumors based on adoptive cell therapies and immune checkpoint blockade therapies.
    Kato D; Yaguchi T; Iwata T; Morii K; Nakagawa T; Nishimura R; Kawakami Y
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(1):68-77. PubMed ID: 28539557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linking Immunity with Genomics in Sarcomas: Is Genomic Complexity an Immunogenic Trigger?
    van Oost S; Meijer DM; Kuijjer ML; Bovée JVMG; de Miranda NFCC
    Biomedicines; 2021 Aug; 9(8):. PubMed ID: 34440251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Will Next-Generation Immunotherapy Overcome the Intrinsic Diversity and Low Immunogenicity of Sarcomas to Improve Clinical Benefit?
    Chew HY; Chan V; Simpson F; Dolcetti R
    Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33207697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunotherapy in Sarcoma: Future Horizons.
    Burgess M; Gorantla V; Weiss K; Tawbi H
    Curr Oncol Rep; 2015 Nov; 17(11):52. PubMed ID: 26423769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging therapeutic approaches for canine sarcomas: Pushing the boundaries beyond the conventional.
    Borgatti A; Dickerson EB; Lawrence J
    Vet Comp Oncol; 2020 Mar; 18(1):9-24. PubMed ID: 31749286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sarcomas: Immune biomarker expression and checkpoint inhibitor trials.
    Zhu MMT; Shenasa E; Nielsen TO
    Cancer Treat Rev; 2020 Dec; 91():102115. PubMed ID: 33130422
    [TBL] [Abstract][Full Text] [Related]  

  • 16. From vision to reality: deploying the immune system for treatment of sarcoma.
    Wilky BA; Goldberg JM
    Discov Med; 2017 Jan; 23(124):61-74. PubMed ID: 28245428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapeutic strategies for sarcoma: current perspectives.
    Li X; Wang G; Cai Z; Sun W
    Am J Transl Res; 2020; 12(12):7693-7701. PubMed ID: 33437354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarcomas-A barren immunological wasteland or field of opportunity for immunotherapy?
    Atherton MJ; Lenz JA; Mason NJ
    Vet Comp Oncol; 2020 Dec; 18(4):447-470. PubMed ID: 32246517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Advances in immune checkpoint inhibitors for bone sarcoma therapy.
    Thanindratarn P; Dean DC; Nelson SD; Hornicek FJ; Duan Z
    J Bone Oncol; 2019 Apr; 15():100221. PubMed ID: 30775238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is immunotherapy in the future of therapeutic management of sarcomas?
    Clemente O; Ottaiano A; Di Lorenzo G; Bracigliano A; Lamia S; Cannella L; Pizzolorusso A; Di Marzo M; Santorsola M; De Chiara A; Fazioli F; Tafuto S
    J Transl Med; 2021 Apr; 19(1):173. PubMed ID: 33902630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.